EFFECTS OF DEGUELIN ON ANTI-CANCER AND MITOCHONDRIAL ENZYMES IN TWO DIFFERENT NON-SMALL CELL LUNG CANCER CELL LINES

Bildik E., Yıldırım A., Kaya Y., Koçdor M. A., Koçdor H.

2024 Balkan Clinical Laboratory Federation (BCLF) Kongresi, Antalya, Turkey, 28 October - 01 November 2024, vol.49, no.1, pp.116-117, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 49
  • Doi Number: 10.1515/tjb-2024-2109
  • City: Antalya
  • Country: Turkey
  • Page Numbers: pp.116-117
  • Dokuz Eylül University Affiliated: Yes

Abstract

Objectives: The aim of this study is to compare the anti-tumorigenic and energy metabolism effects of Deguelin(DEG) with the standard chemotherapeutic agent Docetaxel(DTX) in small cell lung cancer(SCLC) cell lines A549 and H1299.